Lioton 1000 (Heparin Sodium)

Lioton 1000, a heparin sodium product, is employed in clinical situations that require anticoagulation to reduce clot formation.

• Deep vein thrombosis prophylaxis: helps prevent clot development in at‑risk surgical or immobilized patients.
• Pulmonary embolism treatment: aids in dissolving existing clots and preventing new ones in the pulmonary arteries.
• Cardiac surgery anticoagulation: maintains patency of extracorporeal circuits during procedures.
• Acute coronary syndrome management: reduces the risk of further coronary artery occlusion.
• Catheter‑related thrombosis prevention: minimizes clot formation around intravascular devices.

• Heparin Sodium potentiates antithrombin III, which inactivates thrombin (factor IIa) and factor Xa, thereby interrupting the coagulation cascade. This inhibition reduces fibrin formation and limits propagation of existing clots, providing rapid anticoagulant effect across multiple pathways of the clotting system.

Heparin Sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Minor bleeding or bruising at the application site.
• Local skin irritation or erythema.
• Mild thrombocytopenia.
• Elevated liver enzymes.
• Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Heparin‑induced thrombocytopenia (HIT) with paradoxical clotting.
• Major hemorrhage, including intracranial bleeding.
• Spinal or epidural hematoma.
• Severe allergic reactions such as anaphylaxis.
• Osteopenia with prolonged use.
• Adrenal hemorrhage.

When using Lioton 1000, consider the following safety measures.

• Monitor coagulation parameters: regularly assess activated partial thromboplastin time (aPTT) or anti‑Xa levels.
• Assess bleeding risk: avoid use in patients with active or uncontrolled bleeding.
• Review medical history: contraindicated in individuals with known heparin‑induced thrombocytopenia.
• Adjust for age and renal/hepatic function: elderly or organ‑impaired patients may require closer observation.
• Caution with concomitant anticoagulants: increased bleeding potential when combined with other blood thinners.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct light.

Heparin Sodium can interact with several medication classes, influencing its anticoagulant effect.

Major Interactions (Avoid)

• Other anticoagulants (e.g., warfarin, direct oral anticoagulants): additive bleeding risk.
• Antiplatelet agents (e.g., aspirin, clopidogrel): heightened hemorrhage potential.
• Thrombolytic drugs (e.g., alteplase): may cause uncontrolled bleeding.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase gastrointestinal bleeding.
• Certain antibiotics (e.g., quinine, vancomycin): can potentiate anticoagulant effect.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may enhance hypotensive effects when combined with heparin‑related bleeding.
• Corticosteroids: can exacerbate gastrointestinal ulceration.
• Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding tendency.
• Statins: occasional reports of increased bleeding risk.
• Herbal supplements (e.g., ginkgo, garlic): may augment anticoagulant activity.